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ABSTRACT Protective antigen (PA) is the anthrax toxin protein recognized by capillary morphogenesis gene 2 (CMG2), a
transmembrane cellular receptor. Upon activation, seven ligand-receptor units self-assemble into a heptameric ring-like
complex that becomes endocytozed by the host cell. A critical step in the subsequent intoxication process is the formation and
insertion of a pore into the endosome membrane by PA. The pore conversion requires a change in binding between PA and its
receptor in the acidiﬁed endosome environment. Molecular dynamics simulations totaling ;136 ns on systems of over 92,000
atoms were performed. The simulations revealed how the PA-CMG2 complex, stable at neutral conditions, becomes
transformed at low pH upon protonation of His-121 and Glu-122, two conserved amino acids of the receptor. The protonation
disrupts a salt bridge important for the binding stability and leads to the detachment of PA domain II, which weakens the stability
of the PA-CMG2 complex signiﬁcantly, and subsequently releases a PA segment needed for pore formation. The simulations
also explain the great strength of the PA-CMG2 complex achieves through extraordinary coordination of a divalent cation.
INTRODUCTION
Anthrax toxin, secreted by the bacterium Bacillus anthracis,
consists of three proteins: protective antigen (PA), lethal
factor (LF), and edema factor (EF). PA is responsible for the
delivery of the two toxic enzymes, LF and EF, which disrupt
the normal immune function of the host and promote bacterial
survival, as well as induce pathogenesis (see reviews by Collier
and Young (1), Scobie and Young (2), and Moayeri and
Leppla (3)). As the ﬁrst step of the intoxication process, the
full-length 83-kDa PA binds to a receptor on the surface of a
target cell (4,5). A 20-kDa N-terminal fragment of PA is
subsequently cleaved by a furin-like enzyme (6,7). The cleav-
age activates the remaining 63-kDa receptor-bound PA,
which spontaneously assembles into a ring-like heptameric
structure (8). The oligomerization generates binding sites for
up to three molecules of LF and/or EF at the interfaces of neigh-
boring PA monomers (9). The entire toxin-receptor complex
is then internalized into the acidic endosome (10,11). The com-
plex, a prepore structure, undergoes conformational changes
and forms a pore inserted into the membrane of the endosome
(12,13), as illustrated in Fig. 1 a. Through the pore, the toxic
enzymes LF and EF are translocated and released to the cytosol.
Despite the identiﬁcation of the PA residues involved in
the pore formation (14–16), the mechanism for how the PA-
CMG2 complex regulates conformational changes leading to
pore formation (Fig. 1 a) is poorly understood. In the absence
of the receptor, the cleaved PA monomers are still capable of
self-association, and prepore-to-pore conversion occurs at
neutral pH 7 either in artiﬁcial membranes (17) or in solution
(18), whereas the conversion requires an acidic environment
below pH 6 at the receptor-bearing cell surface (17,18). To
understand why the pore formation process is pH dependent
when receptors are present, additional investigations regarding
the interactions between PA and its receptors are necessary.
The anthrax toxin was discovered in the 1950s and the high
resolution crystal structures for all three components involved
in the primary intoxication process have become available
since then (14,19,20); two homologous anthrax receptors
recognized by PA have been identiﬁed recently as well: tumor
endothelial marker 8 (TEM8, or anthrax toxin receptor) (4)
and capillary morphogenesis gene 2 (CMG2) (5). Both
transmembrane receptors share a highly conserved extracel-
lular I domain with a sequence identity of 60%. The crystal
structure of CMG2 I domain alone revealed a so-called
Rossman fold (21), structurally homologs to von Willebrand
factorA type (vWA) proteins best characterized in integrinaA/
I domains (22). Themost distinctive feature of these vWA-type
domains is a structural motif forming the so-called metal ion-
dependent adhesion site (MIDAS), where a divalent metal ion
is acquired by the receptor and is recognized by a negatively
charged amino acid from its ligand. Asp-683PA from PA
domain IV (PAIV) has been pinpointed by genetic analysis and
mutagenesis studies to bind the metal ion at the MIDAS site of
the CMG2 I domain (23,24). However, PA surprisingly binds
CMG2 with an afﬁnity at least 1000-fold higher (25) than that
of a typical integrin-ligand complex (26), which suggests that
additional interactions are involved inPA-CMG2binding (21).
Recently, the crystal structure of monomeric PA in
complex with CMG2 resolved at 2.5 A˚ resolution (27) and
the structure of the heptameric prepore PA-CMG2 assembly
resolved at 4.3 A˚ resolution (18) have conﬁrmed the suggestion.
The structure of the PA-CMG2 complex is shown in Fig. 1 b,
where the domains I–IV of PA are highlighted. In addition to the
bindingof PAIV to theMIDAS regionof the receptor, the crystal
structures revealed interactions between the receptor and PA
domain II (PAII) that aremost intriguingbecause the interactions
prevent the structural rearrangement for prepore-to-pore con-
version. In light of the new crystal structures, it is hypothesized
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that protonation of a histidine residue His-121CMG2 located on
the edge of the binding pocket regulates dissociation of PAII and
triggers the actual pore conversion (18,27). This hypothesis
seems to be promising in solving the long-lasting puzzle of why
the pore formation process is pH dependent.
We have carried out molecular dynamics (MD) simula-
tions to provide structural atomic insights into the pH-regu-
lated stability of the PA-CMG2 complex. We investigated
how the protonation of His-121CMG2 and its neighboring
glutamate Glu-122CMG2 (both receptor side groups) affect
the stability of the complex. The simulations revealed that
the glutamate residue plays an essential role in stabilizing the
prepore PA-CMG2 complex by forming a salt bridge with an
arginine from PA. But the protonation of His-121CMG2 alone
is not enough for disrupting the salt bridge. Protonation of
Glu-122CMG2 is also required to disrupt the salt bridge and to
trigger the dissociation of PAII necessary for initiating pore
formation. We further compare the stability of the equilibrated
neutral structure to an acidic structure with PAII partially
dissociated by means of so-called steered molecular dynamics
(SMD) simulations. SMD is a powerful method for probing
the stability of proteins in silico (28) and has been applied pre-
viously to the probing of the biotin-avidin complex (29,30), to
the study of an integrin-ligand complex (31), to the stretching
of the adhesive extracellular matrix protein ﬁbronectin (32,
33), as well as to the forced dissociation of C-cadherin (34).
METHODS
System setup
The 2.5 A˚ resolution crystal structure of anthrax toxin protein PA in complex
with its receptor, CMG2 I domain (27), was adopted from the Protein Data
Bank (PDB; entry code 1T6B) for modeling. Loops b1b2 and b2b3 of
PAII were poorly resolved in the original structure. The backbones of 28
FIGURE 1 Pore-insertion steps of the an-
thrax intoxication process and the system setup
for the MD simulations conducted in this study.
(a) Heptameric PA-CMG2 anthrax-receptor
complex carrying up to three toxic LF and/or
EF enzymes after endocytosis (left). The acid-
iﬁcation in the endosome triggers the rear-
rangement of each PA monomer (center),
leading to the formation and insertion of a
b-barrel-shaped pore that enables the delivery
of the cargo (right). For a clear view, only four
PA monomers are shown in the center and left
complexes. (b) The crystal structure (PDB code
1T6B) of a PA-CMG2 monomer. The four
domains (I–IV) of PA and the I domain of
CMG2 are colored in cyan, lime, purple, ochre,
and mauve, respectively. The Mg21 ion at the
MIDAS site is shown as an orange sphere.
Unless otherwise noted, the same color code is
used throughout this report. (c) CMG2 domain
I and PAII and PAIV were included in our MD
simulations. Eight histidines and one glutamate
protonated under acidic conditions are colored
in red and blue, respectively. PAIV Asp-683
bound to the MIDAS ion is shown in cyan. The
two PAII loops b1-b2 and b2-b3 missing in
the original crystal structure were built and are
shown in silver. (d) The complex was solvated
and equilibrated in an explicit water cell repre-
sented as a light blue box.
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missing residues in these two loops (residues 276–287, 304–319) were
reconstructed. The side chains of the unresolved residues were subsequently
built and the conformation of these two loops was optimized with Swiss
DeepView (35). The hydrogen atoms of all protein residues were added
using the PSFGEN plug-in of the Visual Molecular Dynamics (VMD)
program (36). The resulting b1b2 and b2b3 loops were minimized for
3000 steps, whereas all other segments of the complex were ﬁxed.
To reduce the size of the system, only PAII (residues 259–456), PAIV
(residues 596–735), and CMG2 domain I (residues 41–210) were included in
theMD simulations. There are ﬁve histidines (residues 263, 299, 304, 310, 336)
in PAII, two (residues 597, 616) in PAIV, and one (residue 121) in CMG2
domain I. To simulate the effect of the acidiﬁed endosome environment, we
designed four systems by varying the protonation state on these eight histidines
and one additional glutamate, Glu-122, neighboring His-121 of CMG2 (see
Results). Crystal water molecules within 10 A˚ distance from the investigated
complexwere retained for building the starting structure of the simulation. Each
system was solvated additionally in a cell of size 873 903 125 A˚3 ﬁlled with
TIP3 (37) water. The dimensions of the water cell were chosen so that the
CMG2 domain can be displaced from the two PA domains by at least 30 A˚
along the longest axis. The crystal structure contains aMn21 ion at theMIDAS
site. SinceMg21 is the physiologically relevant ion, we substituteMg21 for the
Mn21 ion. Additional sodiumor chloride ionswere introduced to neutralize the
systems. The ﬁnal systems, shown in Fig. 1 d, contain ;92,200 atoms.
MD methods
All simulations ware performed using the program NAMD (38) and
CHARMM27 forceﬁelds (39). Periodic boundary conditions were imposed.
Each of the three systems was ﬁrst minimized for two consecutive 2000
conjugate gradient steps, where the protein was held ﬁxed and water molecules
were allowed to move; subsequently, all atoms were allowed to move. After
minimization, each system was equilibrated for 10 ns under constant pressure
and temperature conditions (NPT). The pressure was maintained at 1 atm using
the Langevin piston method (40), and the temperature was controlled by using
Langevin dynamics at 300 K with a damping coefﬁcient of 5 ps1. A Langevin
piston period of 100 fs and a damping time constant of 50 fs were employed for
pressure control.
An integration time step of 1 fs and a uniform dielectric constant of 1 were
chosen. A multiple time step integration algorithm was employed to evaluate
covalent bond interactions every time step, short range nonbonded inter-
actions every two time steps, and long-range electrostatics every four time
steps (41). Full electrostatics were computed using the particle-mesh Ewald
(PME) method (42) with a grid size of 96 3 96 3 128 A˚3. van der Waals
interactions were gradually turned off at a distance between 10 A˚ and 12 A˚.
After equilibration, two sets of constant velocity SMD (cv-SMD)
simulations (28,30) were performed to probe the stability of the complexes.
In a ﬁrst set of SMD simulations, the PAII was stretched from its binding
pocket, whereas CMG2 was ﬁxed. In the second set of simulations, the
CMG2 I domain was pulled away from the binding interface, whereas two
domains of PA were held ﬁxed. To avoid unfolding the protein, the external
force was distributed over the Ca atoms of the b-strands of PAII in the ﬁrst
case and over the Ca atoms of the central b-sheet of the CMG2 domain in the
second case, so that the center of mass of the stretched atoms was har-
monically constrained with a force F ¼ kðvt  xÞ, where k is the spring
constant, v is the velocity, t is the time, and x denotes the displacement along
the pulling direction. Pulling velocities of 0.002 A˚/ps, 0.01 A˚/ps, and 0.05
A˚/ps were chosen. The spring constant k was set to 10 kBT/A˚
2, where kB
denotes the Boltzmann constant and T temperature. When stretching PAII,
the force was applied along the vector pointing fromMIDASMg21 cation to
the Ca atom of Gly-342
PA. In the simulations stretching CMG2, the direc-
tion of the force was along the vector pointing from theMIDASMg21 cation
to the N-terminal Ca atom of the CMG2 domain.
Simulations lasting altogether 136 ns were completed at the National
Center for Supercomputing Applications. A 1 ns simulation of the 92,200
atom system required ;5 h on 128 1.5 GHz Intel Itanium processors.
pKa calculation
The pKa values of the complex and individual CMG2 and PAIV domains
were calculated at the H11 server (43) using the program MEAD (see
Bashford and Gerwert (44) for details). In the calculations the crystal
structure (27) of the complex with missing loops b1b2 and b2b3 rebuilt
was adopted for modeling the protein, which is treated as a low dielectric ein
object with embedded charges. The solvent was modeled as a continuum
with dielectric constant eext. The default dielectric constants ein of 4 and eext
of 80, and a salt concentration 0.15 mol/l were chosen. The ﬁnite difference
Possion-Boltzmann method was used for electrostatics calculations.
RESULTS
To investigate the stability of the PA-CMG2 complex in
neutral and acidic environments, we modeled four systems in
which protonation states of all eight histidines of the complex
and of one glutamate, Glu-122CMG2, neighboring His-121CMG2
(Fig. 1 c) were varied. A neutral system, where none of these
amino acids was protonated, is denoted as the SN structure.
The other three acidic systems will be referred to as the SH
(all histidines protonated), the SE (Glu-122
CMG2 and all histi-
dines but His-121CMG2 protonated), and the SHE (all histi-
dines and Glu-122CMG2 protonated) structures, respectively.
Each of the four systems was equilibrated for 10 ns. To
further examine the binding strength between PA and CMG2,
two sets of cv-SMD simulations (28) were performed after
the equilibration for each of the neutral SN and acidic SHE
structures. In the ﬁrst sets of SMD simulations, PAII was
stretched from its binding pocket on CMG2. In the second
set of SMD simulations, CMG2 domain I was forced
to detach from PA. Simulations totaling altogether ;136 ns
were performed for this study on systems of over 92,000
atoms.
The neutral PA-CMG2 complex maintains a
stable binding interface
Overall the neutral complex (SN) displayed a stable structure
during equilibration, as shown in Fig. 2. The root mean-
squared deviation (RMSD) from the original crystal structure
for backbone heavy atoms of CMG2 domain I and of PAIV
reached 1.25 A˚ and 1.75 A˚, respectively, at 4 ns of the equil-
ibration and subsequently ﬂuctuated around these values
during the remainder of the equilibration (Fig. 2 b). The RMSD
of PAII ﬂuctuated around a higher value of ;3 A˚, mainly due
to the ﬂexible loop segments composed of residues 276289,
297327, 396400, and 422429. The former two loops,
b1b2 and b2b3, are implicated in pore formation (14).
During the equilibration, both binding interfaces between
the receptor and the ligand were slightly enlarged. As shown
in Fig. 2 c, the buried protein surface area (BPSA) between
PAII and CMG2 increased during the equilibration from an
initial value of 630 A˚2 to the average value of 730 A˚2, whereas
it expanded from 1300 A˚2 to the average value of 1410 A˚2
between PAIV and CMG2 (Fig. 2 c). The increase at the
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PAII-CMG2 interface is primarily due to the rearrangement
of the PAII b3b4 loop so that it forms a few new contacts
with the receptor (Fig. 3). Other than the two missing PAII
loops, b1b2 and b2b3, the b3b4 loop region exhibits
the highest mobility in the crystal structure of PAII (aver-
age B factor of 28 A˚2 for the loop residues 340–351 as com-
pared to an average B factor of 19 A˚2 for all resolved PAII
residues). Upon the start of the equilibration at 300 K a short
a-helix (residue 345–351) of the b3b4 loop reoriented
quickly toward the receptor within 50 ps so that the side
chain of Thr-349PA and the backbone hydrogen of Arg-
344PA on the loop form a couple of stabilized hydrogen
bonds with a polar receptor residue Tyr-158CMG2 (Fig. 3, a–b,
and Supplementary Material). In addition, an initially weak
salt bridge between Arg-344PA and Glu-122CMG2 became
stabilized during the equilibration (Fig. 3, see below).
Transitory contacts formed between PAII b3b4 loop resi-
dues (Glu-285PA and Thr-286PA) and the CMG2 a4 helix con-
tributes to the small BPSA peaks observed at 2.8 ns and 8.1
ns for the PAII-CMG2 interface. The increase at the PAIV-
CMG2 interface is mainly caused by new contacts formed
between the PAIV b3b4 loop and the CMG2 a2 helix at
the edge of the binding interface, including side-chain
hydrogen bonds between Asp-648PA and Arg-111CMG2 and
between Glu-650PA and Arg-111CMG2.
The neutral PAII-CMG2 interface develops a
strong Arg-344PA-Glu-122CMG2 salt bridge
Glu-122 is conserved between CMG2 and TEM8, the two
anthrax toxin receptors identiﬁed to date. Sitting at the edge
of the binding interface between PAII and CMG2, Arg-
344PA and Glu-122CMG2 are separated by a distance of at
least 3 A˚ between their side-chain tips, forming only one salt
bridge bond in the crystal structure (Fig. 3 a). Arg-344PA is
located on the PAII loop b3b4, the hairpin tip of which
is inserted into the CMG2 pocket accommodating PAII.
During the equilibration simulation, the guanidinium moiety
of Arg-344PA extended slightly to strengthen the salt bridge
by forming two hydrogen bonds with Glu-122CMG2 (Fig. 3,
a–d). After 5 ns equilibration this bidentate salt bridge
became stabilized as the bonding distance decreased to,2.5
A˚, counteracting occasional disturbances due to attacks from
surrounding water molecules. An analysis of the number of
collision events between water molecules and the two oxygen
atoms on the carboxylic moiety of the Glu-122CMG2, revealing
how frequently the two atoms were contacted by one or two
surrounding water molecules, is shown in Fig. 3 e. No water
molecule approached the deprotonated nitrogen on the side
chain of His-121CMG2, suggesting that this residue cannot be
protonated directly through solvent access.
Unbinding of PAII from the PA-CMG2 complex
requires strong force
To examine the strength of the binding between PAII and
CMG2, we performed cv-SMD simulations (see Methods) in
which PAII was pulled out of its binding pocket spanned by
helices a3 and a4 of CMG2. Results from a representative
cv-SMD simulation at pulling velocity of 0.002 A˚/ps are
shown in Fig. 4. Under a gradually increasing force applied
to the b-strands of PAII, the BPSA of the complex was;770
A˚2 during the ﬁrst 2 ns of the simulation, and then decreased
to 100 A˚2 from 2.4 to 3 ns. Corresponding to this rapid drop,
the applied force decreased from 1000 pN to ;200 pN at
3 ns, and only 2 of 24 contacting residue pairs (deﬁned as
FIGURE 2 Equilibration of the anthrax-
receptor complex under neutral condition. (a)
Cartoon images of the complex before and after
the 10 ns equilibration. In the starting structure,
protein residues implicated in the pore forma-
tion or located at the binding sites are colored
according to the code deﬁned in Fig. 1 b,
whereas in the equilibrated structure they are
colored in orange. For other protein residues,
only their starting structure is shown and
they are colored in gray. The initial and ﬁnal
structures were aligned using the coordinates of
CMG2. Key residues involved in the binding
interactions between PAII and CMG2 and
between Arg-344 of PAII and His-121, Glu-
122, and Tyr-158 of CMG2 are shown in ball
and stick representation. Oxygen, hydrogen,
carbon, and nitrogen atoms are colored in red,
white, cyan, and blue, respectively. (b) The
proﬁles of backbone heavy atom RMSD for the
three domains and the whole complex. The
RMSD values were calculated by aligning individual domains to the crystal structure or in the case of the overall RMSD to the whole complex. (c) Changes of
the BPSAs between PAII and CMG2 and between PAIV and CMG2 over the course of the equilibration.
3270 Gao and Schulten
Biophysical Journal 90(9) 3267–3279
two residues having at least one atom within 3.5 A˚ of each
other) found in the equilibrated structure were still main-
tained at the same time. A closer inspection of speciﬁc
binding interactions revealed that the Arg-344PA-Glu-122CMG2
salt bridge was disturbed at the beginning stage of the SMD
simulation (Fig. 4, d–f). The two original hydrogen bonds
formed during equilibration became broken, weakening
the interaction between Arg-344PA and Glu-122CMG2 as the
interaction energy dropped from 90 kcal/mol to 30 kcal/
mol at 1.5 ns (Figs. 4 d and 3 e). Despite their disturbance,
the two amino acids maintained considerable attractive inter-
actions that were still four times stronger than any of the two
hydrogen bonds formed between Tyr-158CMG2 and Thr-
349PA and between Tyr-158CMG2 and the backbone hydro-
gen of Arg-344PA. These bonds and the salt bridge were
concurrently ruptured at 2.4 ns, leading to the detachment of
PAII from the binding pocket and the release of the origi-
nally restrained b3b4 loop.
Protonation of histidines does not destabilize
the PAII-CMG2 binding
To test the hypothesis that protonation of histidines, par-
ticularly of His-122CMG2, drives the b3b4 loop of PAII
away from the receptor for the purpose of pore formation, we
equilibrated the SH structure in which all histidines of the
complex are protonated. After 10 ns of equilibration, the
RMSD values for backbone heavy atoms of CMG2 and of
PAIV from the crystal structure were ,2 A˚, slightly higher
than that of the neutral structure, whereas the RMSD of PAII
gradually grew to 5 A˚, ;2 A˚ larger than that of the neutral
structure. However, the higher RMSD of PAII primarily
resulted from a swing-like movement of the loop b2b3
containing three histidines (Fig. 5 a). Compared to the
neutral structure, the SH complex preserves a similar binding
interface between PAII and CMG2, as indicated by the close
overlap of the starting and equilibrated loop residues involved
in the binding. The BPSA of the equilibrated PAII-CMG2
complex is ;10% smaller than that of the neutral structure
(Fig. 5 g). Despite this, the ﬂatness of the BPSA curve does
not indicate any tendency of PAII dissociation.
During the initial stage of the equilibration, the protonated
His-121CMG2 attracted Glu-122CMG2 by forming a hydrogen
bond and repelled Arg-344PA so that the Arg-344PA-Glu-
122CMG2 salt bridge was no longer stabilized (Fig. 5 b). Not
retracting from the binding pocket, however, the loop b3
b4 rearranged slightly to allow the reorientation of Arg-
344PA, whichmaintained with Glu-122CMG2 the same bidentate
salt bridge formed during the equilibration of the neutral struc-
ture (Figs. 5 c and 3 c). The salt bridge broke and reformed
several times until it was stabilized after 5 ns equilibration.
Correspondingly, the PAII-CMG2 complex was prevented
from dissociation and the liberation of the b3b4 loop
became impossible.
Protonation of both His-121CMG2 and Glu-122CMG2
leads to the dissociation of PAII from CMG2
Since a protonated His-122CMG2 does not disrupt the Arg-
344PA-Glu-122CMG2 salt bridge, additional regulation is nec-
essary to induce the dissociation of PAII from the PA-CMG2
FIGURE 3 Key contacts at the PAII and
CMG2 binding interface. (a–c) Snapshots of a
salt bridge formed between Arg-344 of PAII
and Glu-122 of CMG2. Formed hydrogen
bonds are represented as dotted black lines.
(d) The interaction energy between Arg-344PA
and Glu-122CMG2 and the distances of two
hydrogen bonds formed between the residues.
(e) Number of water molecules within 2.5 A˚ of
the two oxygen atoms on the side chain of Glu-
122CMG2 or the unprotonated nitrogen of His-
121CMG2.
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complex. Glu-122CMG2 is a straightforward candidate for
playing such a role in a low pH environment. Indeed, we
found that the protonation of both Glu-122CMG2 and His-
121CMG2 triggered the dissociation of PAII from CMG2, as
revealed in the equilibration simulations of the SE (Fig. 5,
d–f ) and SHE structures (Fig. 5, g–i). During the equil-
ibration of the SE structure, where Glu-122
CMG2 and all
histidines other than His-121CMG2 were protonated, Arg-
344PA was repelled from Glu-122CMG2 immediately after the
equilibration started. Moreover, Thr-158CMG2, which was
embedded in a pocket formed by PAII b3b4 loop residues
during the equilibration of the neutral structure (Fig. 2 e),
slipped out of the pocket and resulted in the decrease of the
BPSA of the PAII-CMG2 interface from an initial value of
600 A˚2 to a value of 400 A˚2 at 2.2 ns (Fig. 5 e). However,
further dissociation of PAII was not observed within 10 ns
equilibration as Arg-344PA remained in the proximity of His-
121CMG2 (Fig. 5 f). Instead, Thr-158CMG2 ﬂipped back toward
its original position, restoring partial contacts with the PAII
b3b4 loop. The movement corresponds to an increase of
PAII-CMG2 BPSA to;550 A˚2 at the end of the equilibration.
By comparison, further protonation of His-121CMG2 drove
away Arg-344PA in the equilibration of the SHE structure. After
a 5 ns ﬂuctuation around 700 A˚2, the BPSA of the PAII-CMG2
complex decreased as the dissociation started spontaneously. At
the end of the 10 ns equilibration, the BPSA value dropped to
250 A˚2, i.e., 65% lower than that of the equilibrated neutral
structure. Accompanying this change, the tip of the PAII loop
b3b4 retreated 4 A˚ from the binding pocket on CMG2 for
PAII (Fig. 5 g, and Supplementary Material). Arg-344PA
interacted weakly with Glu-122 during the ﬁrst half of the
equilibration, but it was driven 10 A˚ away at the end of the
FIGURE 4 Probing the binding site
between PAII and CMG2 of the equil-
ibrated neutral complex in a represen-
tative 0.002 A˚/ps cv-SMD simulation.
(a) Force is applied to the b-strands of
PAII along the vector connecting the
MIDAS ion (orange sphere) and the Ca
atom (cyan sphere) of PAII Gly-342.
The force direction is represented by a
yellow arrow. CMG2 is shown in surface
representation. The color code for pos-
itively charged, negatively charged, polar,
and hydrophobic amino acids on the
surface is blue, red, green, and white,
respectively. (b) Proﬁles of applied force
and resulting BPSA between PAII and
CMG2 from the SMD simulation. (c)
Interaction energy versus time proﬁles
for three pairs of residues involved in
binding between PAII and CMG2.
(d–f ) Snapshots of the PAII-CMG2
binding interface showing the disrup-
tion of the Arg-344PA-Glu-122CMG2
salt bridge and a couple of polar in-
teractions between Tyr-158CMG2 and
PAII.
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equilibration (Fig. 5, e–f ). In contrast, the PAIV-CMG2binding
interface was well preserved after the equilibration of all three
acidic structures (SH, SE, and SHE). The BPSA of PAIV-CMG2
is similar to that of the equilibrated SH structure, only ;5%
lower than the BPSA of the neutral structure.
Glu-122CMG2 has a higher pKa value
than His-121CMG2
To examine the likelihood of the protonation of His-121CMG2,
of the neighboringGlu-122CMG2, and of other histidines of the
complex, we calculated the pKa values for these amino acids
using the crystal structure. The resulting pKa values are
shown in Table 1. Whereas histidines on PAII and PAIV
generally have pKa values .4, except His-616PA which is
buried in the hydrophobic core of PAIV, His-121CMG2
exhibits a negative pKa value either in the absence or in the
presence of PA. The primary reason for the low pKa of His-
121CMG2 is that it is partially buried in a valley surrounded by
two ridges comprised of outward-pointing residues on helices
a3 and a4 of the receptor, respectively. The Arg-344PA-Glu-
122CMG2 salt bridge formed between the ligand and receptor
ﬂanks His-121CMG2 farther from the top and virtually
eliminates solvent accessibility of the side chain of this
FIGURE 5 Conformational changes of the anthrax-receptor complex under acidic conditions and interactions of key residues at the PAII-CMG2 binding
surface. (a) Cartoon images of the initial and equilibrated SH structures in which all eight histidines are protonated. The color scheme and the alignment method
are the same as in Fig. 2 a. (b–c) Despite initial disruption, the Arg-344PA-Glu-122CMG2 salt bridge is stably reformed after 5 ns equilibration. (d) Two overlaid
cartoon snapshots of the SE structure where Glu-122
CMG2 and all histidines, but His-121CMG2, are protonated. The snapshot taken at 2.2 ns is colored in the
same scheme as the starting structure in a. The ﬁnal structure reached during the equilibration is shown in orange. (e) The Arg-344PA-Glu-122CMG2 salt bridge
is no longer formed. However, (f) Arg-344PA stays in the proximity of His-121CMG2. (g) Cartoon representations of the starting and 10-ns-equilibrated SHE
structures with Glu-122CMG2 and all eight histidines protonated. In this case (h–i), Arg-344PA separates gradually from Glu-122CMG2. ( j ) Change of BPSA
between PAII and CMG2 over the course of equilibrations of structures SN, SH, SE, or SHE. (k) Proﬁles of the Arg-344
PA-Glu-122CMG2 interaction energy from
these four equilibrations.
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residue. His-121CMG2 therefore has an even lower pKa value
in the complex form compared to that of the receptor-only
form. By comparison, Glu-122CMG2 has a higher pKa of 5 in
the absence of PA. However, the formation of the salt bridge
with Arg-344PA decreases the pKa of Glu-122CMG2 to 2.3.
These values are below the expected pH threshold between
pH 5 to 6 for two reasons: First, interaction between the large
number (over 100) of titratable side chains of the complex
complicates the calculations and likely introduces an error;
second, conformational changes occur in acidic condition
although the crystal structure was determined at basic pH 8
and was used for the pKa calculations. Nevertheless, the
results suggest that the protonation of Glu-122CMG2 likely
happens before that of His-121CMG2.
Separating the PAII b32b4 loop from CMG2
requires weaker force in the SHE structure
compared to the neutral structure
To accelerate the separation of the PAII loop b3b4 from
CMG2, we carried out cv-SMD simulations (see Methods) in
which the PAII-CMG2 binding was completely eliminated
by pulling PAII along the same direction as in the previous set
of SMD simulations. Compared to detaching PAII of the
neutral structure, no major peak force region was encountered
in the case of the SHE structure (Fig. 6 a). The maximum force
required for detaching PAII from CMG2 is ;40–50% lower
than that arising in cv-SMD simulations of the SN structure at
the same pulling velocity ranging from 0.05 A˚/ps to 0.002
A˚/ps (Fig. 6 b). During the equilibration of the SHE structure, a
transient contact was formed between Tyr-158CMG2 and Gly-
342PA when loop b3b4 retreated from the CMG2 binding
pocket (Fig. 6 c). This hydrogen bond was easily disrupted
at 2.65 ns as shown in one representative SMD simulation
(Fig. 6 d).
The binding of PA to CMG2 establishes an optimal
MIDAS cation coordination sphere
Having characterized the PAII-CMG2 binding interactions,
we next examine structural changes at the MIDAS site, the
primary binding site between PAIV and CMG2. As shown
in Fig. 7, the upper surface of CMG2 of the MIDAS site is
encompassed by three loops: a1b1, a2a3, and b4a4.
The MIDAS motif includes Asp-50CMG2, Ser-52CMG2, and
Ser-54CMG2 located on a1b1, Thr-118CMG2 located on
a2a3, and Asp-148CMG2 located on b4a4. The complete
coordination sphere of the MIDAS ion includes Ser-52CMG2,
Ser-54CMG2, Thr-118CMG2, two water molecules W1 and
W2, and Asp-683PA from PAIV (see Fig. 7). Although Asp-
50CMG2 and Asp-148CMG2 do not contact the metal ion
directly, their side-chain carboxylic ﬁngers act together to
ﬁrmly grip water molecule W1. Both water molecules W1
and W2, taken from the crystal structure, are tightly bound to
the ion throughout all three equilibrations.
Loop a2a3 inserts into a hydrophobic pocket ﬂanked by
two loops of PAIV; loop a1b1 contains residues inter-
acting with PAIV (Fig. 7). Comparing the SHE structure to
the SN structure, the movement of loops a1b1 and a2a3
is small because PAIV-CMG2 binding interactions stabiliz-
ing the conformation of these two loops were essentially not
disturbed by the protonation of histidines and Glu-122PA.
A backbone RMSD of ,1 A˚ between the equilibrated SN
and SHE structures was measured for the two loops, which
contain all amino acids of the MIDAS motif except Asp-
148CMG2. In contrast, the dissociation of PAII from the re-
ceptor releases the restraint on the b4a4 loop emanating
from helix a4 that shapes one edge of the binding pocket for
PAII (Fig. 7). The loop displays a backbone RMSD of 2.7 A˚
between the SN and SHE structures. In the latter structure the
conformational changes upon protonation cascaded from
the end at the CMG2 binding pocket to the other end at the
MIDAS region, leading to a 2 A˚ shift of the Asp-148CMG2 Ca
atom (Fig. 7). Accompanying this change is a perturbation
of the tight binding of water W1 to Asp-148CMG2, which ﬂip-
ped its two side-chain carboxylic oxygen atoms to maintain the
water coordination (Fig. 7, inset). By comparison, such ﬂip
behavior was not observed in the equilibration of the neutral
structure, suggesting that the SN structure maintains a more
stabilized MIDAS conﬁguration than does the SHE structure
where PAII become partially dissociated.
TABLE 1 pKa values of seven histidines and one glutamate of the PA-CMG2 complex
CMG2 PAII PAIV Complex
Titratable residue pKintr pKa pKintr pKa pKintr pKa pKintr pKa
His-121CMG2 1.7 1.7 — — — — 4.4 6.3
Glu-122CMG2 5.6 5.0 — — — — 7.4 2.1
His-263PA — — 5.0 5.7 — — 5.1 5.6
His-299PA — — 5.3 4.6 — — 4.9 4.0
His-304PA — — 4.1 4.2 — — 4.2 3.8
His-310PA — — 6.3 6.3 — — 6.3 6.3
His-336PA — — 6.3 6.9 — — 5.6 5.2
His-597PA — — — — 4.2 8.8 4.2 8.8
His-616PA — — — — 3.1 1.1 3.2 0.8
The calculation was performed for separated individual domains CMG2, PAII, and PAIV, as well as for the whole complex. The intrinsic pK, denoted as
pKintr, is deﬁned as the pKa of a titratable group when all other titratable groups of the protein were neutral.
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Dissociation of PAII weakens the
PA-CMG2 complex
To compare the overall stability of the equilibrated SN and
SHE complexes, the latter with PAII partially dissociated, cv-
SMD simulations were conducted for each complex sepa-
rating PA from CMG2, as sketched in Fig. 8 a. In both cases,
i.e., SN and SHE, a prominent force peak was observed con-
sistently in the force versus time proﬁles obtained from 15
independent cv-SMD simulations at various stretching veloc-
ities (Fig. 8, b and c). The major force peaks correspond to
destabilizing the coordination through the MIDAS ion, as
shown in two series of snapshots from two representative
0.002 A˚/ps cv-SMD simulations (Fig. 8, d–m, and Supple-
mentary Material). However, the scenarios of the destabilization
are different. Disrupting the SN complex requires signiﬁcantly
higher force than disrupting the SHE structure, due to the
tightness of the binding between PAII and the receptor.
In the representative SMD simulation of the neutral com-
plex (Fig. 8, d–h), the contacts between the receptor and the
MIDAS ion were greatly weakened at 4.46 ns, coinciding with
a precipitous decrease of the pulling force from over 3000 pN to
,500 pN (Fig. 8 b). Immediately after the force peak, the
MIDAS coordination residues Ser-52CMG2 and Thr-118CMG2
were replaced by two water molecules coordinating the
MIDAS ion (Fig. 8 f). The BPSA between PAIV and CMG2
decreased from 1000 A˚2 to 300 A˚2 at 4.6 ns. However, the Arg-
344PA-Glu-122CMG2 salt bridge and other interactions between
PAII and CMG2 were still maintained. At 5 ns, CMG2 was
completely detached from the binding interface of PAIV, tilting
;60 toward PAII (Fig. 8 g). The remaining contacts were
ruptured sequentially by a rather weak force.
PAII is largely dissociated from CMG2 in the equilibrated
SHE structure. The SMD force easily disrupted a transient
contact formed between Tyr-158CMG2 and Gly-342PA, the
rupture occurring at 2.47 ns in one representative SMD
simulation of the acidic structure (Fig. 8, b and j). By the
time of occurrence of the peak force at 3.5 ns, the stretching
had diminished the BPSA between CMG2 and PAII to 80
A˚2. The peak force of 2000 pN coincides with the breakage
of the contacts between the MIDAS water W1 and receptor
residues Asp-50CMG2 and Asp-148CMG2. The conﬁguration
of the latter had already been disturbed during the equili-
bration of the acidic complex (see Fig. 7). The release of water
W1 allowed the molecule to attack the remaining MIDAS ion
coordination. W1 subsequently facilitated the separation of
MIDAS coordination residue Ser-52CMG2 from the ion by
replacing the coordination of Ser-52CMG2 (Fig. 8 l). At 4.02
ns, the interactions between the MIDAS ion and two sur-
rounding serines were ruptured. At this point, the BPSA between
PAIV and CMG2 started a rapid decrease from 900 A˚2 to 300 A˚2
at 4.5 ns, and the pulling force dropped from 2000 pN to below
500 pN. As the stretching continued, the remaining receptor-
ligand contacts were easily abolished without encountering a fur-
ther major force peak. Based on the average from 30 independent
simulations pulling SN and SHE structures at velocities of 0.05 A˚/
ps, 0.01 A˚/ps, and 0.002 A˚/ps, the peak unbinding force was
consistently found ;20% lower for the acidic complex com-
pared to that of the neutral complex (Fig. 8 c). Decreasing the
pulling velocity 25-fold reduced the peak force by;30% in each
FIGURE 6 Forced detachment of PAII from
the CMG2 binding pocket in SMD simulations of
the SHE structure. (a) Proﬁles of applied force and
BPSA between PAII and CMG2 from a repre-
sentative 0.002 A˚/ps cv-SMD simulation. (b)
Comparison of peak forces required to unbind
PAII from CMG2 between the SN and the SHE
structures in cv-SMD stretching simulations with
various constant velocities. Signiﬁcantly lower
force is required to detach PAII when the Arg-
122PA-Glu-122CMG2 salt bridge is broken under
low pH conditions. (c–d) Snapshots of the PAII-
CMG2 binding interface obtained from the
representative SMD simulation.
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case, leaving the key features of the scenarios described
unchanged.
DISCUSSION
One key question regarding the anthrax intoxication mech-
anism is how the heptameric PA-CMG2 complex initiates
formation of a b-barrel-like pore for ferrying its toxic cargo.
It was suggested that the PA segment lining the eventual
14-b-stranded barrel, i.e., loops b1-b2, b2-b3, and b3-b4
and b-strands b2 and b3, becomes dislodged from the PAII
domain upon acidiﬁcation in the endosome environment
(14). However, the new crystal structures exhibit an unan-
ticipated PAII-CMG2 binding that inhibits the rearrange-
ment and dislodging of these secondary structures (18,27).
On the other hand, it was known that low acidic conditions
are required for pore formation. Early studies suggest that
prepore initiation proceeds under acidic condition between
pH 5 and 6 (8,17). Recent experiments indicate that the
threshold for converting the PA-CMG2 prepore complex to the
pore is between pH 5.2 and 5.5 (45). Therefore, the apparent
contradiction caused by the PAII-CMG2 binding can be
reconciled if PAII dissociates from CMG2 under low pH
conditions (18,27). Addressing this important issue, our MD
simulations provide structural insights into the mechanism for
the pH-regulated PA-CMG2 binding and conformational
change relevant to pore formation.
One consistent ﬁnding is that PAII orients its b3b4 loop
under neutral condition so that Arg-344PA stabilizes a salt
bridge formed with the conserved receptor amino acid Glu-
122CMG2. The breakage of this salt bridge was detected as the
key event during both mechanical unbinding via applying
external force and chemical unbinding through lowering pH.
The peak pulling force for detaching PAII from the complex
corresponds to abolishing the salt bridge. In simulations of
low pH structures, the salt bridge became disrupted before
PAII dissociated from the binding site. Therefore, the Arg-
344PA-Glu-122CMG2 salt bridge is identiﬁed as the key con-
tributor to the functionally relevant PAII-CMG2 binding
interaction.
Our simulations also suggest that the protonation of His-
121CMG2 alone only slightly alters the conﬁguration of Arg-
344PA, which remains capable of forming a salt bridge with
Glu-122CMG2. The observation that the Arg-344PA-Glu-
122CMG2 salt bridge is stably reformed after the initial
interruption upon protonating His-121CMG2 implies that addi-
tional structural changes related to the low pH condition are
required for releasing PAII. However, since the accessible
timescale of MD simulations is limited to tens of nanosec-
onds, we cannot rule out the possibility that PAII dissociates
from CMG2 on a much longer timescale upon the proton-
ation of only His-121CMG2. As an alternative, we propose that
Glu-122CMG2 also plays a role in triggering the dissociation
of PAII under low pH conditions. First, the protonation of
FIGURE 7 Conformational changes of the
MIDAS coordination sphere region upon the
dissociation of PAII from CMG2. The equili-
brated SN structure is shown in gray. The equil-
ibrated SHE structure, where PAII becomes
partially dissociated, is colored following the
code deﬁned in Fig. 1 b. Residues not belonging
to the binding sites on CMG2 are dimmed. The
SN and SHE structures were aligned using the
coordinates of CMG2. The amino acids and
water molecules W1 and W2 coordinating the
MIDAS cation are shown in licorice representa-
tion. The coordination of water W1 by Asp-
148CMG2 is disturbed due to the dissociation of
PAII in the SHE structure. Shown in the inset are
the proﬁles for the distance between MIDAS
water W1 and two side-chain oxygens of Asp-
148CMG2 over the course of the equilibration of
SN and SHE structures.
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the Glu-122CMG2 carboxylate side chain eliminates the salt
bridge, greatly weakening the interactions between PAII
and CMG2. Second, the protonation of Glu-122CMG2 creates
the solvent accessibility for protonating His-121CMG2, the
titratable nitrogen on the tip of His-121CMG2 being buried by
the salt bridge and inaccessible to solvent as long as the salt
bridge is formed. The protonation of both His-121CMG2 and
Glu-122CMG2 initiates rapid dissociation of PAII.
Although the anthrax receptor CMG2 I domain resembles
integrin aA/I domains adopting a homologous MIDAS
binding motif (23), binding assays have shown that the
afﬁnity constant KD associated with the binding between
FIGURE 8 Forced dissociation of the receptor CMG2 from the ligand PA in cv-SMD simulations. (a) The force is applied to the centralb-sheet of CMG2 along
the direction pointing from Mg21 to the Ca atom of the CMG2 N-terminus, as indicated by a blue arrow. (b) Force versus time proﬁles from one representative
0.002 A˚/ps cv-SMD simulation of the SN and SHE structures. (c) Comparison of the peak unbinding force calculated in 30 SMD simulations of the SN ()) and the
SHE (s) structure. Each symbol represents an independent simulation. Note that two close symbols may overlap. Snapshots obtained from the representative
cv-SMD simulations (d–h) of the SN structure and (i–m) of the SHE structure. The trajectories of these two simulations are provided as movies in the Supplementary
Material. Water molecules coordinating the MIDAS ion are shown in light blue.
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anthrax toxin PA and its receptor CMG2 is;200 pM (25), at
least 1000-fold higher than KD for integrin-ligand complexes
(26). To explain the extremely high afﬁnity of the anthrax-
receptor complex, additional binding interactions between
PA and CMG2 have been postulated. Indeed, along with the
MIDAS interactions between PAIV and the receptor, a
second binding site between PAII and CMG2 was unveiled
in the crystal structures of the complex (18,27). Although
the conﬁguration of the MIDAS motif on CMG2 exhibits
the same ‘‘open’’ form as typical integrin aA/I domains
(26,46,47), the second binding site is conserved only be-
tween PA receptors but not seen in integrin aA/I domains.
Consistent with previous biochemical and crystallography
data, our SMD study demonstrates that PA-CMG2 is a very
stable complex as a strong force is required to rupture it. In
particular, the PAII-CMG2 binding contributes signiﬁcantly
to the stability of the complex. Forced separation of PAII in
the equilibrated neutral complex results in a force peak twice
that of detaching PAII in the acidic SHE complex where PAII
became partially dissociated before the stretching. The force
peak detected in the latter case is similar to the maximum
force required for destabilizing an integrin aVb3-ligand com-
plex investigated previously (31). However, we note that a
different type of cation (Mn21 instead of Mg21) was adopted
in the previous SMD study and that integrin aVb3 belongs to
a subset of integrins where the aA/I domain is absent and the
binding to its ligand is achieved via a homologous MIDAS
ion on its bA/I domain.
The MIDAS interactions play a major role in stabilizing
thewhole complex because the peak force for separatingCMG2
from the ligand consistently correlates with the disruption of
the MIDAS contacts. The SMD simulations further revealed
a mechanism by which the PA-CMG2 complex achieves a
high afﬁnity state through maintaining the conﬁguration of
the MIDAS coordination sphere. On CMG2 the MIDAS site
is linked to the PAII binding site through the loop b4a4.
The PAII-CMG2 interactions restrict the movement of the
b4a4 loop bearing Asp-148CMG2, which acts with Asp-
50CMG2 to ﬁrmly seize one of two water molecules coordi-
nating the MIDAS cation. The coordination is important for
stabilizing the PA-CMG2 complex as mutating Asp-50CMG2
to alanine eliminates PA binding (23). When the PAII-
CMG2 binding was weakened in the SHE structure, loop
b4a4 became more ﬂexible, and the coordination to the
water molecule was easily disrupted as Asp-148CMG2 was
stretched away, followed by the breakage of the Asp-50CMG2-
water contact. The water molecule W1 subsequently attacked
one of the remaining receptor-MIDAS ion contacts, resulting
in a much lower peak force than that required for disrupting the
intact MIDAS coordination sphere exhibited in the neutral
structure. It has been shown that the tight coordination of water
molecules by the divalent MIDAS cation shields the attack of
free water molecules to the motif residues, thus stabilizing the
binding interactions (31). Extending this conclusion, our study
now provides an illustration of how the tight coordination of a
MIDAS water molecule by both the MIDAS ion and the
receptor dramatically enhances the MIDAS interactions.
Many toxin proteins secreted by bacteria initiate their
invasion through a pore inserted into the membrane of a host
cell (48). The pH-regulated tight binding between the
anthrax toxin and its receptor delays pore formation until
the complex has been taken up by the host cell and trans-
located to a destination close to its targets. The MD simu-
lations conducted by us provide structural insights into how
the anthrax-receptor complex stabilizes itself and how the
stability is weakened through protonation of a few amino
acids. We have shown that the binding between PAII and
CMG2 contributes signiﬁcantly to the overall stability of the
complex. The PAII-CMG2 binding is regulated by His-
121CMG2 and Glu-122CMG2, two conserved amino acids at
the binding pocket of the receptor. The protonation of both
residues disrupts a salt bridge characterizing the binding sta-
bility, which is necessary for releasing PAII for the purpose
of pore formation.
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